Welcome to CDC stacks | The National Healthcare Safety Network (NHSN) manual; biovigilance component - 13213 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All Simple Search
Advanced Search
The National Healthcare Safety Network (NHSN) manual; biovigilance component
  • Published Date:
    July 2010
Filetype[PDF-692.62 KB]

  • Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.), Division of Healthcare Quality Promotion. ; National Healthcare Safety Network ;
  • Description:
    National Healthcare Safety Network (NHSN) -- Biovigilance component -- Using the NHSN Hemovigilance module -- Appendix A. Adverse reaction case definition criteria -- Appendix B. Adverse reaction clinical and laboratory definitions -- Appendix C. Adverse reaction severity and imputability definitions -- Appendix D. Antibodies associated with hemolytic transfusion reactions -- Appendix E. NHSN occupation codes -- Appendix F. NHSN incident codes -- Appendix G. Incident definitions

    The NHSN is a secure, internet-based surveillance system that integrates former CDC surveillance systems, including the National Nosocomial Infections Surveillance System (NNIS), National Surveillance System for Healthcare Workers (NaSH), and the Dialysis Surveillance Network (DSN). NHSN enables healthcare facilities to collect and use data about healthcare-associated infections, adherence to clinical practices known to prevent healthcare-associated infections, the incidence or prevalence of multidrug-resistant organisms within their organizations, trends and coverage of healthcare personnel safety and vaccination, and adverse events related to the transfusion of blood and blood products. Some U.S. states utilize NHSN as a means for healthcare facilities to submit data on healthcare-associated infections (HAIs) mandated through their specific state legislation. The NHSN includes four components, each concerned with various aspects of control and prevention of HAIs. Those four components are Patient Safety, Healthcare Personnel Safety, Biovigilance, and Research and Development. NHSN users do not use the Research and Development Component of the system. NHSN users do however, access and participate in the Patient Safety, Healthcare Personnel Safety, and Biovigilance Components of NHSN. A facility (acute care hospital, ambulatory surgery center, outpatient dialysis center) may use one, two, or all three NHSN components concurrently. The Biovigilance Component of NHSN was developed in collaboration with the transfusion and transplant communities. Biovigilance includes the collection of adverse event data to improve outcomes in the use of blood products, organs, tissues, and cellular therapies. The Hemovigilance Module is the first module of the Biovigilance Component to be developed in NHSN. This module is designed for staff in healthcare facility transfusion services to track adverse events, including recipient adverse reactions and quality control incidents, related to blood transfusion.

  • Place as Subject:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: